Han, Jindi
-
Vol 14, No 6 (June 30, 2022): Journal of Thoracic Disease - Original Article
The overall survival benefit in Chinese ALK+ NSCLC patients received targeted therapies
Details PDF Full Text Reporting Checklist Data Sharing Statement COI Form